Cargando…

Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches

Detalles Bibliográficos
Autores principales:	Zagidullin, Naufal, Cai, Benzhi, Zhu, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667595/ https://www.ncbi.nlm.nih.gov/pubmed/34912232 http://dx.doi.org/10.3389/fphar.2021.807645

Ejemplares similares

Cyclin L1 controls cardiomyocyte proliferation and heart repair after injury
por: Gong, Rui, et al.
Publicado: (2023)

Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration
por: Gong, Rui, et al.
Publicado: (2021)

Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
por: Tong, Xiaoyong, et al.
Publicado: (2023)

Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications
por: Guo, Xiaofei, et al.
Publicado: (2018)

Targeting cardiomyocyte proliferation as a key approach of promoting heart repair after injury
por: Li, Shuainan, et al.
Publicado: (2021)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
por: Fiedler, Lukas, et al.
Publicado: (2023)

Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance
por: Singh, Chandra Kant, et al.
Publicado: (2023)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation
por: Zulkarneev, Rustem, et al.
Publicado: (2012)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

The Impact of Remote Ischemic Preconditioning on Arterial Stiffness and Heart Rate Variability in Patients with Angina Pectoris
por: Zagidullin, Naufal, et al.
Publicado: (2016)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases
por: Su, Jian-Hui, et al.
Publicado: (2021)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)

Luteolin: A Flavonoid that Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms
por: Luo, Yuanyuan, et al.
Publicado: (2017)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Editorial: Stem Cells as Targeted Drug Delivery Vehicles
por: Kusuma, Gina D., et al.
Publicado: (2020)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Editorial: Adenylyl cyclase isoforms as potential drug targets
por: Brust, Tarsis F., et al.
Publicado: (2022)

Editorial: New Approaches in Toxicity Testing of Nanotherapeutics
por: Kalangi, Suresh K., et al.
Publicado: (2022)

Editorial: Computational and Experimental Approaches in Multi-target Pharmacology
por: Anastasio, Thomas J.
Publicado: (2017)

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2021)

Editorial: Growth factors and stem cells intervention in injury repair and regeneration of spinal cord and peripheral nerve
por: Chen, Min, et al.
Publicado: (2023)

Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
por: Bulatov, Emil, et al.
Publicado: (2018)

Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Lymphatic delivery and targeting of drugs, vaccines, and imaging agents
por: Han, Sifei, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Orexin, cardio-respiratory function, and hypertension
por: Li, Aihua, et al.
Publicado: (2014)

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update
por: Soghomonyan, S., et al.
Publicado: (2021)

Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain
por: Nieto, Francisco Rafael, et al.
Publicado: (2020)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases
por: Uddin, Md. Jamal, et al.
Publicado: (2022)

Editorial: Innovative pharmacometric approaches to inform drug development and clinical use
por: Garcia-Cremades, Maria, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3abjpu6so8ojhllu37tm9ecrv2